MCL1 and ischemic disease: Sepsis (58), ischemic disease (63), and autoimmune diseases (64) showed high levels of soluble TM in serum and plasma that reflected prevailing endothelial injury, indicating that soluble TM levels might be useful for disease diagnosis (Table 1B).